1 |
Cines DB, Bussel JB, Liebman HA, Luning Prak ET. The ITP syndrome: pathogenic and clinical diversity. Blood 2009;113:6511-21.
DOI
ScienceOn
|
2 |
Cines DB, Blanchette VS. Immune thrombocytopenic purpura. N Engl J Med 2002;346:995-1008.
DOI
|
3 |
Khandekar MM, Khurana AS, Deshmukh SD, Kakrani AL, Katdare AD, Inamdar AK. Platelet volume indices in patients with coronary artery disease and acute myocardial infarction: an Indian scenario. J Clin Pathol 2006;59:146-9.
DOI
ScienceOn
|
4 |
Fruchter O, Blich M, Jacob G. Fatal acute myocardial infarction during severe thrombocytopenia in a patient with idiopathic thrombocytopenic purpura. Am J Med Sci 2002;323:279-80.
DOI
ScienceOn
|
5 |
Paolini R, Zamboni S, Ramazzina E, Zampieri P, Cella G. Idiopathic thrombocytopenic purpura treated with steroid therapy does not prevent acute myocardial infarction: a case report. Blood Coagul Fibrinolysis 1999;10:439-42.
DOI
ScienceOn
|
6 |
Elkayam O, Paran D, Milo R, et al. Acute myocardial infarction associated with high dose intravenous immunoglobulin infusion for autoimmune disorders. A study of four cases. Ann Rheum Dis 2000;59:77-80.
DOI
ScienceOn
|
7 |
Patrassi GM, Sartori MT, Rigotti P, et al. Coagulation and fibrinolysis during the first year of immunosuppressive treatment in renal transplantation: correspondence between hypercoagulable state and steroid therapy. Clin Appl Thromb Hemost 1995;1:277-82.
DOI
|
8 |
Stangel M, Hartung HP, Marx P, Gold R. Side effects of high-dose intravenous immunoglobulins. Clin Neuropharmacol 1997;20:385-93.
DOI
|
9 |
Fisman DN, Smilovitch M. Intravenous immunoglobulin, blood viscosity and myocardial infarction. Can J Cardiol 1997;13:775-7.
|
10 |
Caputo RP, Abraham S, Churchill D. Transradial coronary stent placement in a patient with severe idiopathic autoimmune thrombocytopenic purpura. J Invasive Cardiol 2000;12:365-8.
|
11 |
Moretti C, Teresa Lucciola M, Morena L, et al. Idiopathic thrombocytopenic purpura and percutaneous coronary stenting: a dangerous duo? Int J Cardiol 2008;130:e96-7.
DOI
|
12 |
Russo A, Cannizzo M, Ghetti G, et al. Idiopathic thrombocytopenic purpura and coronary artery disease: comparison between coronary artery bypass grafting and percutaneous coronary intervention. Interact Cardiovasc Thorac Surg 2011;13:153-7.
DOI
|
13 |
Fong MC, Chen KC, Leu HB, Chen LC. Coronary revascularization in a patient with immune thrombocytopenic purpura. J Chin Med Assoc 2006;69:436-8.
DOI
|
14 |
Neskovic AN, Stankovic I, Milicevic P, et al. Primary PCI for acute myocardial infarction in a patient with idiopathic thrombocytopenic purpura. A case report and review of the literature. Herz 2010;35:43-9.
DOI
|
15 |
Agostoni P, Biondi-Zoccai GG, de Benedictis ML, et al. Radial versus femoral approach for percutaneous coronary diagnostic and interventional procedures; Systematic overview and meta-analysis of randomized trials. J Am Coll Cardiol 2004;44:349-56.
DOI
ScienceOn
|
16 |
Chevalier B, Lancelin B, Koning R, et al. Effect of a closure device on complication rates in high-local-risk patients: results of a randomized multicenter trial. Catheter Cardiovasc Interv 2003;58:285-91.
DOI
|
17 |
Yellin A, Refaely Y, Paley M, Simansky D. Major bleeding complicating deep sternal infection after cardiac surgery. J Thorac Cardiovasc Surg 2003;125:554-8.
DOI
|
18 |
Mathew TC, Vasudevan R, Leb L, Pezzella SM, Pezzella AT. Coronary artery bypass grafting in immune thrombocytopenic purpura. Ann Thorac Surg 1997;64:1059-62.
DOI
ScienceOn
|
19 |
Inoue Y, Lim RC, Nand P. Coronary artery bypass grafting in an immune thrombocytopenic purpura patient using off-pump techniques. Ann Thorac Surg 2004;77:1819-21.
DOI
ScienceOn
|
20 |
Ascione R, Williams S, Lloyd CT, Sundaramoorthi T, Pitsis AA, Angelini GD. Reduced postoperative blood loss and transfusion requirement after beating-heart coronary operations: a prospective randomized study. J Thorac Cardiovasc Surg 2001;121:689-96.
DOI
ScienceOn
|